Search results
Results from the WOW.Com Content Network
After sustaining an uptrend on the markets since bottoming in February, GlaxoSmithKline (NYSE:GSK) still has an attractive profile for income and value investors. The stock’s rock-solid dividend ...
On the dividend front, the pharmaceutical giant delivers a 3.25% yield supported by a healthy 64.4% payout ratio. The company's track record shows consistent dividend increases, with 7.68% annual ...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see...
The stagnating price paired with dividend raises and the prospect of earnings growth has pushed the share's dividend yield up to 3% and the forward price-to-earnings ratio (P/E) down to just 21.5 ...
Investors can approximate the average market return by buying an index fund. While individual stocks can be big...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
GSK (GSK) closed at $30.65 in the latest trading session, marking a +0.92% move from the prior day.